Actemra

News

AbbVie closes on Rinvoq approval in inflamed artery disease

AbbVie's Rinvoq is poised to become the first oral targeted treatment for giant cell arteritis in the EU after being backed by the CHMP.

News

Biogen claims first with FDA nod for biosimilar Actemra

Biogen says it is the first drugmaker in the US to get FDA approval for a biosimilar of Roche’s $3 billion blockbuster product Actemra.

News

EU has its first RoActemra biosimilar, from Fresenius Kabi

The European Commission has approved the first biosimilar version of Actemra/RoActemra, Roche’s $3 billion blockbuster, from German drugmaker Fresenius Kabi.

News

As pandemic abates, NICE issues new COVID drug guidance

NICE says it is the first HTA to give guidance on the drugs outside of use during the pandemic.

News

Olumiant benefits additive to other drugs in severe COVID pa...

Eli Lilly and Incyte's JAK inhibitor Olumiant reduced the risk of death by 13% in hospitalised COVID-19 patients when added to other drugs, according to new results from the UK RECOVERY tri

News

EU approves Roche's Actemra for severe COVID-19

The European Commission has moved swiftly to grant full approval to Roche's Actemra/RoActemra as a treatment for severe COVID-19, clearing the drug within 24 hours of a recommendation from

AbbVie closes on Rinvoq approval in inflamed artery disease

Biogen claims first with FDA nod for biosimilar Actemra

EU has its first RoActemra biosimilar, from Fresenius Kabi

As pandemic abates, NICE issues new COVID drug guidance

Olumiant benefits additive to other drugs in severe COVID pa...

EU approves Roche's Actemra for severe COVID-19

FDA approves higher Wegovy dose via 4th priority voucher

Using AI-driven synthetic personas to take your insights fur...

Actemra

Editor's Picks